UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000025843 |
|---|---|
| Receipt number | R000029718 |
| Scientific Title | Inositol treatment for polycystic ovary syndrome (PCOS): Systematic review and meta-analysis |
| Date of disclosure of the study information | 2017/02/01 |
| Last modified on | 2019/01/10 17:43:15 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Inositol treatment for polycystic ovary syndrome (PCOS): Systematic review and meta-analysis
Acronym
Inositol treatment for PCOS
Scientific Title
Inositol treatment for polycystic ovary syndrome (PCOS): Systematic review and meta-analysis
Scientific Title:Acronym
Inositol treatment for PCOS
Region
| Japan |
Condition
Condition
polycystic ovary syndrome
Classification by specialty
| Obstetrics and Gynecology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the effect of inositol on outcome in PCOS.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Parameters of glucose metabolism
Ovarian function
Key secondary outcomes
Serum sex hormone
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
All randomized controlled trial comparing inositol with placebo intake in PCOS are included in this study.
Key exclusion criteria
We exclude studies that is not report our primary and secondary outcomes.
We also exclude studies that did not set appropriate control group, is review article and is not clinical study.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Makoto Nakano |
Organization
Yokohama University of Pharmacy
Division name
General Health Medical Center
Zip code
Address
601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN
TEL
045-859-1300
m.nakano@hamayaku.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kohsuke Hayamizu |
Organization
Yokohama University of Pharmacy
Division name
Laboratory of Food Chemistry
Zip code
Address
601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN
TEL
045-859-1300
Homepage URL
k.hayamizu@hamayaku.ac.jp
Sponsor or person
Institute
Yokohama University of Pharmacy
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 02 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 01 | Month | 13 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 01 | Month | 26 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Preparing to submit a paper
Management information
Registered date
| 2017 | Year | 01 | Month | 25 | Day |
Last modified on
| 2019 | Year | 01 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029718
